Platelet-derived growth factor B restores vascular barrier integrity and diminishes permeability in ovarian hyperstimulation syndrome

PASCUALI, NATALIA; SCOTTI, LEOPOLDINA; OUBIÑA, GONZALO; DE ZÚÑIGA, IGNACIO; PEÑA, GOMEZ; POMILIO, CARLOS; SARAVIA, FLAVIA; TESONE, MARTA; ABRAMOVICH, DALHIA; PARBORELL, FERNANDA

MOLECULAR HUMAN REPRODUCTION.

OXFORD UNIV PRESS

Año: 2020

1360-9947

Although advances in the prediction and management of ovarian hyperstimulation syndrome (OHSS) have been introduced, complete prevention is not yet possible. Previously, we and other authors have shown that vascular endothelial growth factor, angiopoietins (ANGPTs) and sphingosine-1-phosphate are involved in OHSS etiology. In addition, we have demonstrated that ovarian protein levels of platelet-derived growth factor (PDGF) ligands -B and -D decrease in an OHSS rat model, whilst PDGFR-β and ANGPT2 remain unchanged. In the present work, we investigated the role of PDGF-B in OHSS by evaluating ligand protein levels in follicular fluid (FF) from women at risk of developing OHSS and by using an immature rat model of OHSS. We demonstrated that PDGF-B and PDGF-D are lower in FF from women at risk of developing OHSS compared to control patients (p < 0.05). In the OHSS rat model, PDGF-B (0.5 µg/ovary) administration decreased ovarian weight (p < 0.05), reduced serum progesterone (p < 0.05) and lowered the percentage of cysts (p < 0.05), compared to untreated OHSS rats, but had no effect on the proportion of follicles or corpora lutea (CL). PDGF-B treatment also restored the expression of steroidogenic acute regulatory protein (p < 0.05) and P450 cholesterol side-chain cleavage enzyme (p < 0.01) to control levels. In addition, PDGF-B increased the peri-endothelial cell area in CL and cystic structures, and reduced vascular permeability compared to untreated OHSS ovaries. Lastly, PDGF-B increased the levels of junction proteins claudin-5 (p < 0.05), occludin (p < 0.05) and β-catenin (p < 0.05), while boosting the extracellular deposition of collagen IV surrounding the ovarian vasculature (p < 0.01), compared to OHSS alone. In conclusion, our findings indicate that PDGF-B could be another crucial mediator in the onset and development of OHSS, which may lead to the development of novel prediction markers and therapeutic strategies.